Teijin to Acquire MedTech Heart

March 05 2018

Teijin Limited has reached an agreement with M3i, Inc. located in Tokyo Japan to acquire a controlling interest in MedTech Heart, a company that researches and develops medical devices in Japan. Once Teijin takes possession of 93.8% of the stock held by the Seeds Rocket limited liability partnership, a venture capital company in the M3, Inc. group, it will turn the company into a consolidated subsidiary named Teijin MedTecHeart Co., Ltd. by the end of March 2018. The acquisition includes MedTecHeart GmbH, a German subsidiary of MedTech Heart, a company that also researches and develops medical devices in Europe.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [52]
Chemical [263]
Composites & Advanced Materials [167]
Construction & Industrial [72]
Consumer and Retail [142]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [79]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [164]
Transportation [141]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on